0000939767-18-000100.txt : 20180524 0000939767-18-000100.hdr.sgml : 20180524 20180524201612 ACCESSION NUMBER: 0000939767-18-000100 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180524 FILED AS OF DATE: 20180524 DATE AS OF CHANGE: 20180524 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MORRISSEY MICHAEL CENTRAL INDEX KEY: 0001202096 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30235 FILM NUMBER: 18859429 MAIL ADDRESS: STREET 1: C/O EXELIXIS INC STREET 2: 170 HARBOR WAY CITY: SAN FRANCISCO STATE: CA ZIP: 94083 FORMER NAME: FORMER CONFORMED NAME: MORRISSEY MICHAEL M DATE OF NAME CHANGE: 20030512 FORMER NAME: FORMER CONFORMED NAME: MORRISSEY MICHAEL R DATE OF NAME CHANGE: 20021029 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EXELIXIS, INC. CENTRAL INDEX KEY: 0000939767 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043257395 STATE OF INCORPORATION: DE FISCAL YEAR END: 0102 BUSINESS ADDRESS: STREET 1: 210 E. GRAND AVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6508377000 MAIL ADDRESS: STREET 1: 210 E. GRAND AVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS INC DATE OF NAME CHANGE: 20000207 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20000106 4 1 wf-form4_152720735854904.xml FORM 4 X0306 4 2018-05-24 0 0000939767 EXELIXIS, INC. EXEL 0001202096 MORRISSEY MICHAEL C/O EXELIXIS, INC. 210 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 1 1 0 0 President and CEO Common Stock 2018-05-24 4 M 0 90000 5.50 A 215000 D Common Stock 2018-05-24 4 S 0 90000 20.55 D 125000 D Common Stock 176351 I By Trust Common Stock 17354 I By 401(k) Option (right to buy) 5.5 2018-05-24 4 M 0 90000 0 D 2012-09-28 2018-09-27 Common Stock 90000.0 270000 D Includes 125,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and excludes 6,653 shares previously owned directly which were contributed to the Morrissey Family Living Trust dated July 21, 1994, as amended. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2018. Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.22 to $20.72. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of May 23, 2018. The option, representing the right to purchase a total of 450,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 28, 2015. /s/ Jennifer Drimmer Rokovich, Attorney in Fact 2018-05-24